Fwd: 714X getting a Hearing for approval to National Cancer Institute (NCI)

[Guest guest]

arnoldgore

Thu, 3 Jul 2003 14:52:01 EDT

714X getting a Hearing for approval to National Cancer Institute (NCI)

 

 

 

The good news is that this product has gotten a bit closer to

legitimacy. I know several men who have used it (cost of about 300

dollars U.S. per month) for PCa but they said it didn't work for them

and the Canadian company told me that they have not had much success

with PCa in general. I also have met the two people mentioned in the

article below. In addition to speaking with them, I have seen Katie

Hartley's MRI'S, and video taped meetings with her onco. These are

two very remarkable young people who have not only survived cancer

but have been in complete remission for a number of years. Thier

doctors at Dana Farber cancer institute are baffled . The story of

this product and this medical institution is a long and contentious

one. Dana Farber has done many things over the years to discredit

714X , even when they inadvertantly tested it believeing it to be

something else and offered the manufacturer a deal , until they found

out they were dealing with 715X. Should be very interesting how this

one turns out as the manufacturer has submitted 16 names of patients

who have been cured so if the advisory board which meets in private

wants to discredit it, they are going to have to do some very fancy

foot work.

 

The not so good news with ominous implications is the

elimination of ''The Cancer Advisory Panel for Complementary and

Alternative Medicine''. This is a giant step in the wrong direction.

 

 

 

bostonherald.com

 

Feds to review claims of cure with alternative cancer drug

 

by Michael Lasalandra

Tuesday, July 1, 2003

 

The National Cancer Institute has set a July 21 meeting to review

cases of patients who say they have been cured by a controversial

alternative cancer drug, including the case of Billy Best, who made

headlines when he ran away from his Norwell home nine years ago to

avoid chemotherapy treatments.

 

 

The meeting is seen by supporters as a hopeful step in getting the

government to approve the drug, 714X, which was developed by Canadian

biologist Gaston Naessens and is available in Canada.

 

``We're going into it with an open mind and an open heart,'' said

Suzanne Cliche, spokeswoman for CERBE Distribution, Naessens' company.

 

In addition to the case of Best, who says he cured his lymphoma using

714X, the meeting will also hear the case of Katie Harley of Duxbury,

who was apparently cured of cancer in her face by the medication.

 

Five case studies will be presented by Dr. Jeffrey White, director of

the NCI's Office of Cancer Complementary and Alternative Medicine, to

an NCI advisory panel made up mostly of conventional cancer

specialists and researchers.

 

While Naessens and his wife, Jacinte, will be allowed to hear White's

presentation, they will be excluded from listening to the panel when

it discusses the cases and makes recommendations.

 

The entire session will be closed to the public and the media. White

said secrecy is necessary because such presentations usually involve

proprietary information about products and the names of patients,

which must be kept confidential.

 

In a letter to Naessens, White said a National Institutes of Health

advisory panel that had been set up to review so-called ``best

cases'' of alternative cancer treatments has been disbanded.

 

The Cancer Advisory Panel for Complementary and Alternative Medicine

was rescinded by the Department of Health and Human Services,

reportedly to reduce the number of advisory committees. The panel had

advised the National Center for Complementary and Alternative

Medicine, which is part of NIH.

 

``It's a bureaucratic issue,'' White said, adding that he is hopeful

the situation is only temporary.

 

The drug, which is injected directly into the lymphatic system,

contains mineral salts, camphor and a variety of trace elements. It

is said to boost the body's immune system and repair damaged cells.

 

White, a medical oncologist, said he has been impressed with the case

studies he has reviewed. ``It's an interesting group of reports,'' he

said. ``I'm very anxious to see what the panel thinks. My sense is

that they are interested in looking at this and giving back the best

answers they can.''

 

The panel's recommendation could help get the NCI to fund a study of

714X, although White said his office could act on its own to approve

smaller-scale studies.

 

 

 

 

 

 

Copyright by the Boston Herald and Herald Interactive Advertising

Systems, Inc.

 

 

 

 

 

 

Gettingwell- / Vitamins, Herbs, Aminos, etc.

 

To , e-mail to: Gettingwell-

Or, go to our group site: Gettingwell

 

 

 

SBC DSL - Now only $29.95 per month!